Check out an engaging webinar with Dr. Mark Gold, M.D., a renowned expert in addiction and psychiatry. Dr. Gold explores emerging challenges in treating substance use disorders, sharing insights from his recent publications. Topics include the role of exercise in recovery, the impact of genetic inheritance on substance use disorders, medications for opioid use disorder, and new findings on treating tobacco addiction.
Dr. Gold's extensive research offers valuable knowledge to clinicians, healthcare professionals, and the general public. In one of his recent articles, he highlights how exercise can aid recovery by stimulating the brain's reward system, helping to manage and reduce cravings. He also discusses genetic factors in substance use disorders, including the discovery of 47 genetic variants linked to these conditions and the complex role genetics play in both increasing and reducing risk.
Speaker
Dr. Mark Gold, M.D., is a trailblazing figure in addiction and psychiatry, known for his transformative contributions across multiple medical fields. With over 1,000 peer-reviewed publications and 30,000 academic citations, his work has left an indelible mark on the medical community. Dr. Gold is a founding member and director of the McKnight Brain Institute and is celebrated for modernizing addiction medicine training. His pioneering research on opioid dependence led to groundbreaking theories on addiction and withdrawal, and he discovered the effectiveness of alpha-2 adrenergic agonists, such as clonidine and lofexidine, in easing withdrawal symptoms. Collaborating with colleagues, he revolutionized addiction psychiatry by introducing evidence-based care and medication-assisted treatments. His insights have advanced opioid use disorder treatments and expanded our understanding of cocaine's impact on dopamine and addiction. As a visiting professor, editor, and researcher, Dr. Gold continues to influence the field of translational neuroscience.
Read Dr. Gold's full bio here.